Skip to main content

Early Keytruda Results Win Merck An Upgrade

By: via Benzinga
Merck & Co., Inc. (NYSE: MRK) announcedencouraging dataTuesday from a key study of patients with lung cancer. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.